Enriqueta Felip, MD, PhD - Targeting TROP2 in Advanced NSCLC: What Do We Know From Recent Clinical Trials?

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Science

Share Enriqueta Felip, MD, PhD - Targeting TROP2 in Advanced NSCLC: What Do We Know From Recent Clinical Trials?

Sign up to save your podcasts

Enriqueta Felip, MD, PhD - Targeting TROP2 in Advanced NSCLC: What Do We Know From Recent Clinical Trials?

Enriqueta Felip, MD, PhD - Targeting TROP2 in Advanced NSCLC: What Do We Know From Recent Clinical Trials?

More shows like PeerVoice Heart & Lung Audio

PeerVoice Brain Behaviour Audio

PeerVoice Oncology & Haematology Audio

PeerVoice Endocrinology & Metabolic Disorders Audio

PeerVoice Endocrinology & Metabolic Disorders Video

PeerVoice Digestive Diseases Audio

PeerVoice Digestive Diseases Video

PeerVoice Immunology & Infectious Disease Video

PeerVoice Immunology & Infectious Disease Audio

PeerVoice Internal Medicine Audio

PeerVoice Internal Medicine Video